Institute and Department of Psychiatry, School of Medicine, University of São Paulo, São Paulo, Brazil &middot Neuropsychopharmacology Unit, Division of Experimental Medicine, Imperial College London, London, UK. &middot School of Psychiatry & Clinical Neurosciences (M521), The University of Western Australia, Perth, WA, Australia. &middot Centre for Addiction and Mental Health, University of Toronto, Toronto, ON, Canada. &middot Institute and Department of Psychiatry, School of Medicine, University of São Paulo, São Paulo, Brazil. · Pubmed 26187054

A Lifetime Prevalence of Comorbidity Between Bipolar Affective Disorder and Anxiety Disorders: A Meta-analysis of 52 Interview-based Studies of Psychiatric Population. 2015

Evidence for serotonin function as a neurochemical difference between fear and anxiety disorders in humans? 2015

Evidence-based pharmacological treatment of anxiety disorders, post-traumatic stress disorder and obsessive-compulsive disorder: a revision of the 2005 guidelines from the British Association for Psychopharmacology. 2014

The effect of 6-week treatment with escitalopram on CCK-4 challenge: a placebo-controlled study in CCK-4-sensitive healthy volunteers. 2013

Stratified medicine in psychiatry: a worrying example or new opportunity in the treatment of anxiety? 2013

Institute and Department of Psychiatry, School of Medicine, University of São Paulo, São Paulo, Brazil &middot Neuropsychopharmacology Unit, Division of Experimental Medicine, Imperial College London, London, UK. &middot School of Psychiatry & Clinical Neurosciences (M521), The University of Western Australia, Perth, WA, Australia. &middot Centre for Addiction and Mental Health, University of Toronto, Toronto, ON, Canada. &middot Institute and Department of Psychiatry, School of Medicine, University of São Paulo, São Paulo, Brazil. · Pubmed 26187054